Enovis (ENOV) Change in Accured Expenses (2010 - 2011)
Enovis' (ENOV) quarterly Change in Accured Expenses came in at -$9.4 million in Q4 2011, down 159.9% year-over-year from $15.7 million in Q4 2010, and down 1109.98% quarter-over-quarter from $932000.0 in Q3 2011.
Powered by 
Analysis
Enovis (ENOV) Change in Accured Expenses (2010 - 2011) Analysis & Trends
Enovis (ENOV) has reported Change in Accured Expenses for 2 consecutive years, with -$9.4 million the latest figure, recorded in Q4 2011.
- On a quarterly basis, Change in Accured Expenses fell 159.9% year-over-year to -$9.4 million in Q4 2011; TTM through Dec 2011 was $16.0 million, a N/A change from a year earlier, with the FY2011 full-year figure at -$10.9 million, down 150.1% from the prior year.
- Change in Accured Expenses was -$9.4 million for Q4 2011 at Enovis, down from $932000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $15.7 million in Q4 2010 and troughed at -$9.4 million in Q4 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | -74.00 Mn |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | -9.41 Mn |
| Sep 30, 2011 | 932,000.00 |
| Dec 31, 2010 | 15.72 Mn |
| Oct 1, 2010 | 8.74 Mn |